FORT MYERS, FL / ACCESSWIRE / July 25, 2016 / NeoGenomics, Inc. (NASDAQ: NEO) will host a conference call and live webcast to discuss the results of the second quarter 2016, to be held Tuesday, July 26, 2016 at 11:00 AM Eastern Time.

To participate in this event, dial 877-407-8035 domestically, or 201-689-8035 internationally, approximately 5 to 10 minutes before the beginning of the call. Additionally, you can listen to the event online at www.investorcalendar.com/IC/CEPage.asp?ID=175124 as well as via the NeoGenomics website (www.neogenomics.com).

If you are unable to participate during the live webcast, the event archive will be available at www.investorcalendar.com or www.neogenomics.com.

You may access the teleconference replay by dialing 877-481-4010 domestically or 919-882-2331 internationally, referencing conference ID # 10043. The replay will be available beginning approximately 2 hours after the completion of the live event, ending at midnight Eastern on August 9, 2016.

About NeoGenomics, Inc.

NeoGenomics, Inc. specializes in cancer genetics testing and information services. The Company provides one of the most comprehensive oncology-focused testing menus in the world for Physicians to help them diagnose and treat cancer. The Company's BioPharma division serves pharmaceutical clients in clinical trials and drug development.

Headquartered in Fort Myers, FL, NeoGenomics operates CLIA certified laboratories in Aliso Viejo, Fresno, Irvine, and West Sacramento, California; Tampa and Fort Myers, Florida; Houston, Texas and Nashville, Tennessee. NeoGenomics serves the needs of pathologists, oncologists, academic centers, hospital systems, integrated service delivery networks, and managed care organizations throughout the United States. For additional information about NeoGenomics, visit www.neogenomics.com.

SOURCE: Investor Calendar